Authors:
Le Monte, AM
Goldman, M
Smedema, ML
Connolly, PA
McKinsey, DS
Cloud, GA
Kauffman, CA
Wheat, LJ
Citation: Am. Le Monte et al., DNA fingerprinting of serial Candida albicans isolates obtained during itraconazole prophylaxis in patients with AIDS, MED MYCOL, 39(2), 2001, pp. 207-213
Authors:
Kauffman, CA
Vazquez, JA
Sobel, JD
Gallis, HA
McKinsey, DS
Karchmer, AW
Sugar, AM
Sharkey, PK
Wise, GJ
Mangi, R
Mosher, A
Lee, JY
Dismukes, WE
Citation: Ca. Kauffman et al., Prospective multicenter surveillance study of funguria in hospitalized patients, CLIN INF D, 30(1), 2000, pp. 14-18
Authors:
Winstead, JM
McKinsey, DS
Tasker, S
De Groote, MA
Baddour, LM
Citation: Jm. Winstead et al., Meningococcal pneumonia: Characterization and review of cases seen over the past 25 years, CLIN INF D, 30(1), 2000, pp. 87-94
Authors:
Goldman, M
Cloud, GA
Smedema, M
LeMonte, A
Connolly, P
McKinsey, DS
Kauffman, CA
Moskovitz, B
Wheat, LJ
Citation: M. Goldman et al., Does long-term itraconazole prophylaxis result in in vitro azole resistance in mucosal Candida albicans isolates from persons with advanced human immunodeficiency virus infection?, ANTIM AG CH, 44(6), 2000, pp. 1585-1587
Authors:
McKinsey, DS
Wheat, LJ
Cloud, GA
Pierce, M
Black, JR
Bamberger, DM
Goldman, M
Thomas, CJ
Gutsch, HM
Moskovitz, B
Dismukes, WE
Kauffman, CA
Citation: Ds. Mckinsey et al., Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: Randomized, placebo-controlled, double-blind study, CLIN INF D, 28(5), 1999, pp. 1049-1056